MR images taken during the systole phase improve diagnoses of scars on the heart

April 13, 2013

MR images taken when the ventricles of the heart relax and fill with blood and then when the ventricles contract and eject blood to the rest of the body provide a more complete picture of the extent of myocardial scar in patients with ischemic cardiomyopathy, a new study finds.

Detection of scar is important because it helps identify patients who are at higher risk of a fatal event, said Dr. James Fernandez, the first author of the study.

The to determine scar in these patients is to collect just diastolic data (when the ventricles relax), said Dr. Fernandez. "However, our study of 30 patients at the University of Southern California found that images taken during the systolic cardiac phase (when the ventricles contract) can show scars not seen on images taken in the diastolic phase," Dr. Fernandez said. "Scars were seen in 23 studies in diastole versus 25 studies in systole," he said. In three studies, systolic images showed beneath the , an area prone to ischemic damage, that were not detectable on diastolic images," Dr. Fernandez said.

The study will be part of the electronic exhibit program at the ARRS Annual Meeting in Washington, DC.

Explore further: Good transplant outcomes in hypertrophic cardiomyopathy

Related Stories

Good transplant outcomes in hypertrophic cardiomyopathy

August 17, 2012
(HealthDay) -- Post-heart transplant survival does not differ significantly between patients with hypertrophic cardiomyopathy (HC) and those with other types of heart disease, according to a study published in the Aug. 15 ...

Erectile dysfunction drug fails for diastolic heart failure patients

March 12, 2013
Despite high expectations for a commonly used erectile dysfunction drug to treat patients with diastolic heart failure, no beneficial effects were found in a study presented today at the American College of Cardiology's 62nd ...

Diastolic dysfunction of the heart associated with increased risk of death

June 27, 2011
Individuals with diastolic dysfunction (an abnormality involving impaired relaxation of the heart's ventricle [pumping chamber] after a contraction) appear to have an increased risk of death, regardless of whether their systolic ...

Electronic cigarettes do not damage the heart

August 26, 2012
Smoking is the most preventable risk factor for cardiac and lung disease and is expected to cause 1 billion deaths during the 21st century. Electronic cigarettes have been marketed in recent years as a safer habit for smokers, ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.